Title:
[1,3]THIAZOL-2-AMINE COMPOUND, APPLICATION, AND PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2018/121267
Kind Code:
A1
Abstract:
A [1,3]thiazol-2-amine compound, an application, and a pharmaceutical composition. The present invention belongs to the field of BACE inhibitors. The [1,3]thiazol-2-amine compound is a compound represented by formula (I), or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof. The compound has a good inhibitory effect on BACE, and can be used in preparing a drug for treating a neurodegenerative disease, such as Alzheimer's disease.
Inventors:
WU YUSHENG (CN)
LIANG APENG (CN)
NIU CHENGSHAN (CN)
GENG YANG (CN)
LI JINGYA (CN)
LIANG APENG (CN)
NIU CHENGSHAN (CN)
GENG YANG (CN)
LI JINGYA (CN)
Application Number:
PCT/CN2017/116031
Publication Date:
July 05, 2018
Filing Date:
December 14, 2017
Export Citation:
Assignee:
TETRANOV PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K31/382; C07D279/04; A61K31/542; A61P25/28; C07D417/12; C07D417/14; C07D513/04
Domestic Patent References:
WO2011009898A1 | 2011-01-27 | |||
WO2009091016A1 | 2009-07-23 | |||
WO2006138264A2 | 2006-12-28 |
Foreign References:
EP2511269A1 | 2012-10-17 |
Attorney, Agent or Firm:
CHINA WISPRO INTELLECTUAL PROPERTY LLP. (CN)
Download PDF:
Previous Patent: METHOD AND DEVICE FOR OBTAINING APPLICATION AND TERMINAL DEVICE
Next Patent: POWER GENERATION DEVICE
Next Patent: POWER GENERATION DEVICE